Canagliflozin


( Last Updated : February 24, 2014)
Generic Name:
Canagliflozin
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus, type 2
Manufacturer:
Janssen Inc.
Call for patient/clinician input open:
Brand Name:
Invokana
Project Line:
Reimbursement Review
Project Number:
SR0370-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Submission Type:
Initial
Indications:
Diabetes Mellitus, Type 2
Recommendation Type:
List with criteria/condition
Final Recommendation: